Machine learning and its potential applications to the genomic study of head and neck cancer—A systematic review

Abstract

BackgroundMachine learning (ML) is powerful tool that can identify and classify patterns from large quantities of cancer genomic data that may lead to the discovery of new biomarkers, new drug targets, and a better understanding of important cancer genes. The aim of this systematic review was to evaluate the existing literature and assess the application of machine learning of genomic data in head and neck cancer (HNC).Materials and methodsThe addressed focused question was “Does machine learning of genomic data play a role in prognostic prediction of HNC?” PubMed, EMBASE, Scopus, Web of Science, and gray literature from January 1990 up to and including May 2018 were searched. Two independent reviewers performed the study selection according to eligibility criteria.ResultsA total of seven studies that met the eligibility criteria were included. The majority of studies were cohort studies, one a case‐control study and one a randomized controlled trial. Two studies each evaluated oral cancer and laryngeal cancer, while other one study each evaluated nasopharyngeal cancer and oropharyngeal cancer. The majority of studies employed support vector machine (SVM) as a ML technique. Among the included studies, the accuracy rates for ML techniques ranged from 56.7% to 99.4%.ConclusionOur findings showed that ML techniques for the analysis of genomic data can play a role in the prognostic prediction of HNC.

Machine learning and treatment outcome prediction for oral cancer

“…All 12 models in this study performed reasonably, although DT using 34 prognostic features was best at predicting OSCC progression, achieving 71% accuracy but only 42% sensitivity. There are few comparable data in the literature, although a recent systematic review reported SVM accuracy between 56.7 and 99.4% 26 . In a study of 311 early‐stage tongue SCCs, an artificial neural network (ANN) was used to characterize invasive histopathology and achieved 88% accuracy and 71% sensitivity for loco‐regional recurrence prediction, 16 whilst a decision forest algorithm to predict occult nodal metastasis in 71 T1/T2 OSCC patients reported an AUC of 0.84, with 91.7% sensitivity and 57.6% specificity 17 .…”

The use of artificial intelligence, machine learning and deep learning in oncologic histopathology

“…While deep learning has made significant advances and progressed the field of oncologic pathology, its use with respect to oral oncology is still in the nascent stage (Table 1) however, the extent of data analyzed was limited to demographic, clinicopathologic, or genomic data. 26,[30][31][32] Chang et al 33 38,39 Thus, future studies focused on OPMDs would greatly benefit the field especially in tackling the large intra-and inter-observer variability that occurs in oral dysplasia grading.…”

Improvement of oral cancer screening quality and reach: The promise of artificial intelligence

“…AI may also contribute positively to prognostic evaluation of oral cancer patients. For example, ML techniques for the analysis of genomic data can play a role in the prognostic prediction of head and neck squamous cell carcinomas 22 …”